Pillstats
Rx only · Tablet, Film Coated, Extended Release · Oral

Oxybutynin

Oxybutynin Chloride

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US9 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCG04BD04
RxCUI (US)32675
US makers4 labelers
Packages39
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.030$0.060$0.090$0.120Dec 2025Apr 2026Jul 2026
$0.097
Latest avg · Jul 22, 2026
-6%
Since Dec 17, 2025
4
Active US suppliers
92%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

36K71K107K143K2025 Q12025 Q22025 Q32025 Q42026 Q1
115K
Rx · 2026 Q1
5.1M
Units dispensed
+2%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Zydus Lifesciences Limitedunknown18SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown18SUPPLYING
NCS HealthCare of KY, LLC dba Vangard Labsunknown2SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Oct 19, 2023
    RECALLRecall (Class II): Oxybutynin Chloride Extended-Release Tablet USP, 5 mg, 100 count bottles, Rx Only, Manufactured by: Cadila Healthcare L…

    Failed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point. — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide.

  • Oct 19, 2023
    RECALLRecall (Class II): Oxybutynin Chloride Extended-Release Tablet USP, 15 mg, 100 count bottles, Rx Only, Manufactured by: Cadila Healthcare …

    Failed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point. — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide.

  • Oct 19, 2023
    RECALLRecall (Class II): Oxybutynin Chloride Extended-Release Tablet USP, 10 mg, 100 count bottles Rx Only, Manufactured by: Cadila Healthcare …

    Failed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point. — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide.

  • Sep 21, 2023
    RECALLRecall (Class II): Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 68382-256-01) and b) 500 tablets (NDC 68382…

    Failed Dissolution Specifications — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide in the USA.